Concepts (152)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hematopoietic Stem Cells | 8 | 2021 | 325 | 1.010 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 3 | 2016 | 170 | 0.890 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 3 | 2015 | 182 | 0.600 |
Why?
|
| Adult Stem Cells | 1 | 2016 | 32 | 0.480 |
Why?
|
| Leukemia, Myeloid, Acute | 4 | 2019 | 824 | 0.440 |
Why?
|
| Cell Proliferation | 4 | 2016 | 1753 | 0.420 |
Why?
|
| Hematopoiesis | 6 | 2021 | 182 | 0.390 |
Why?
|
| Neoplastic Stem Cells | 4 | 2019 | 173 | 0.360 |
Why?
|
| Disease Progression | 2 | 2015 | 1561 | 0.360 |
Why?
|
| Potentially Inappropriate Medication List | 2 | 2020 | 2 | 0.310 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2009 | 85 | 0.310 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2009 | 204 | 0.290 |
Why?
|
| Gene Expression Regulation, Leukemic | 2 | 2015 | 99 | 0.220 |
Why?
|
| Protein Kinase C-alpha | 2 | 2015 | 29 | 0.200 |
Why?
|
| Mice | 12 | 2019 | 12525 | 0.200 |
Why?
|
| Signal Transduction | 2 | 2014 | 3581 | 0.190 |
Why?
|
| Inappropriate Prescribing | 2 | 2020 | 21 | 0.190 |
Why?
|
| GATA2 Transcription Factor | 1 | 2019 | 16 | 0.150 |
Why?
|
| Mice, Inbred C57BL | 5 | 2019 | 3483 | 0.150 |
Why?
|
| Cellular Microenvironment | 1 | 2019 | 30 | 0.150 |
Why?
|
| Pharmacies | 1 | 2019 | 12 | 0.150 |
Why?
|
| Unfolded Protein Response | 1 | 2019 | 48 | 0.150 |
Why?
|
| B-Lymphocytes | 2 | 2015 | 760 | 0.140 |
Why?
|
| Respiratory Physiological Phenomena | 1 | 2019 | 49 | 0.140 |
Why?
|
| Animals | 13 | 2019 | 28901 | 0.140 |
Why?
|
| Dyspnea | 1 | 2019 | 87 | 0.140 |
Why?
|
| Cell Hypoxia | 2 | 2015 | 187 | 0.140 |
Why?
|
| Mitochondria | 2 | 2019 | 621 | 0.140 |
Why?
|
| Gene Deletion | 2 | 2015 | 358 | 0.130 |
Why?
|
| Fumarate Hydratase | 1 | 2017 | 8 | 0.130 |
Why?
|
| Students, Medical | 1 | 2022 | 455 | 0.120 |
Why?
|
| RNA-Binding Proteins | 1 | 2019 | 305 | 0.120 |
Why?
|
| Cells, Cultured | 3 | 2016 | 2928 | 0.120 |
Why?
|
| Reactive Oxygen Species | 1 | 2019 | 516 | 0.120 |
Why?
|
| Thymus Neoplasms | 1 | 2016 | 47 | 0.120 |
Why?
|
| Genomic Instability | 1 | 2016 | 88 | 0.120 |
Why?
|
| Lymphoma, T-Cell | 1 | 2016 | 61 | 0.120 |
Why?
|
| Cell Survival | 2 | 2015 | 1029 | 0.120 |
Why?
|
| Myeloid Ecotropic Viral Integration Site 1 Protein | 1 | 2015 | 20 | 0.120 |
Why?
|
| Multiprotein Complexes | 1 | 2016 | 108 | 0.120 |
Why?
|
| Adenosine Triphosphatases | 1 | 2016 | 155 | 0.120 |
Why?
|
| Mice, Knockout | 5 | 2019 | 2160 | 0.110 |
Why?
|
| Immunity, Innate | 1 | 2019 | 464 | 0.110 |
Why?
|
| Protein Kinase C beta | 1 | 2015 | 13 | 0.110 |
Why?
|
| CRISPR-Cas Systems | 1 | 2015 | 98 | 0.110 |
Why?
|
| Mutation, Missense | 1 | 2016 | 302 | 0.110 |
Why?
|
| Disease Models, Animal | 3 | 2019 | 2534 | 0.110 |
Why?
|
| Dendritic Cells | 1 | 2019 | 539 | 0.110 |
Why?
|
| Cell Division | 1 | 2016 | 701 | 0.110 |
Why?
|
| Neoplasms | 1 | 2009 | 3242 | 0.100 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2015 | 150 | 0.100 |
Why?
|
| Cell Surface Extensions | 1 | 2013 | 11 | 0.100 |
Why?
|
| Megakaryocytes | 1 | 2013 | 38 | 0.100 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2013 | 58 | 0.100 |
Why?
|
| Basement Membrane | 1 | 2013 | 57 | 0.090 |
Why?
|
| Neoplasm Proteins | 1 | 2015 | 547 | 0.090 |
Why?
|
| Cell Dedifferentiation | 1 | 2012 | 10 | 0.090 |
Why?
|
| Myeloid Progenitor Cells | 1 | 2012 | 16 | 0.090 |
Why?
|
| Mice, Transgenic | 1 | 2016 | 1642 | 0.090 |
Why?
|
| PAX5 Transcription Factor | 1 | 2012 | 33 | 0.090 |
Why?
|
| Lymphoid Progenitor Cells | 1 | 2012 | 16 | 0.090 |
Why?
|
| Base Sequence | 1 | 2015 | 2341 | 0.090 |
Why?
|
| Leukemia | 1 | 2014 | 305 | 0.090 |
Why?
|
| Homeodomain Proteins | 1 | 2015 | 563 | 0.090 |
Why?
|
| Molecular Sequence Data | 1 | 2015 | 3040 | 0.090 |
Why?
|
| Extracellular Matrix | 1 | 2013 | 255 | 0.090 |
Why?
|
| DNA-Binding Proteins | 1 | 2016 | 1267 | 0.080 |
Why?
|
| Chromatin | 1 | 2013 | 445 | 0.080 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2013 | 684 | 0.080 |
Why?
|
| Death-Associated Protein Kinases | 1 | 2009 | 6 | 0.080 |
Why?
|
| Gene Expression Profiling | 1 | 2015 | 1533 | 0.080 |
Why?
|
| Cell Line, Tumor | 1 | 2015 | 2776 | 0.080 |
Why?
|
| Cell Self Renewal | 2 | 2019 | 23 | 0.080 |
Why?
|
| Humans | 12 | 2022 | 95992 | 0.070 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2013 | 1347 | 0.070 |
Why?
|
| Nursing Homes | 2 | 2020 | 113 | 0.070 |
Why?
|
| RNA, Small Interfering | 2 | 2019 | 562 | 0.070 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2009 | 416 | 0.060 |
Why?
|
| Germ-Line Mutation | 1 | 2009 | 382 | 0.060 |
Why?
|
| Polymorphism, Genetic | 1 | 2009 | 832 | 0.060 |
Why?
|
| Epigenesis, Genetic | 1 | 2009 | 555 | 0.060 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 3 | 2019 | 942 | 0.060 |
Why?
|
| Female | 6 | 2019 | 49980 | 0.050 |
Why?
|
| Immunoglobulin Heavy Chains | 2 | 2015 | 129 | 0.050 |
Why?
|
| Mice, Inbred ICR | 2 | 2013 | 77 | 0.050 |
Why?
|
| Models, Biological | 1 | 2009 | 1810 | 0.050 |
Why?
|
| Smartphone | 1 | 2022 | 54 | 0.040 |
Why?
|
| Psychometrics | 1 | 2022 | 340 | 0.040 |
Why?
|
| Serbia | 1 | 2020 | 3 | 0.040 |
Why?
|
| Male | 4 | 2016 | 45792 | 0.040 |
Why?
|
| Bone Marrow Transplantation | 1 | 2021 | 291 | 0.040 |
Why?
|
| THP-1 Cells | 1 | 2019 | 9 | 0.040 |
Why?
|
| X-Box Binding Protein 1 | 1 | 2019 | 20 | 0.040 |
Why?
|
| Hexokinase | 1 | 2019 | 22 | 0.040 |
Why?
|
| Citric Acid Cycle | 1 | 2019 | 28 | 0.040 |
Why?
|
| Bone Marrow | 1 | 2021 | 415 | 0.040 |
Why?
|
| Toll-Like Receptors | 1 | 2019 | 101 | 0.040 |
Why?
|
| RNA Interference | 1 | 2019 | 385 | 0.030 |
Why?
|
| Healthy Volunteers | 1 | 2019 | 157 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2019 | 207 | 0.030 |
Why?
|
| Respiratory Mechanics | 1 | 2019 | 114 | 0.030 |
Why?
|
| Fumarates | 1 | 2017 | 20 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2019 | 890 | 0.030 |
Why?
|
| Chromosome Structures | 1 | 2016 | 2 | 0.030 |
Why?
|
| Metaphase | 1 | 2016 | 21 | 0.030 |
Why?
|
| Anaphase | 1 | 2016 | 20 | 0.030 |
Why?
|
| Thymocytes | 1 | 2016 | 31 | 0.030 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2017 | 51 | 0.030 |
Why?
|
| Oxygen Consumption | 1 | 2017 | 253 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2022 | 2885 | 0.030 |
Why?
|
| Leukemic Infiltration | 1 | 2015 | 14 | 0.030 |
Why?
|
| ZAP-70 Protein-Tyrosine Kinase | 1 | 2015 | 18 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2020 | 10307 | 0.030 |
Why?
|
| Lymphoid Tissue | 1 | 2015 | 58 | 0.030 |
Why?
|
| Immunoglobulin Variable Region | 1 | 2015 | 110 | 0.030 |
Why?
|
| Histones | 1 | 2017 | 362 | 0.030 |
Why?
|
| Transduction, Genetic | 1 | 2015 | 162 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2021 | 1662 | 0.030 |
Why?
|
| T-Cell Acute Lymphocytic Leukemia Protein 1 | 1 | 2013 | 4 | 0.030 |
Why?
|
| Nucleoside-Phosphate Kinase | 1 | 2013 | 3 | 0.030 |
Why?
|
| GATA1 Transcription Factor | 1 | 2013 | 19 | 0.030 |
Why?
|
| K562 Cells | 1 | 2013 | 49 | 0.030 |
Why?
|
| Jurkat Cells | 1 | 2013 | 84 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2022 | 2860 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2015 | 322 | 0.030 |
Why?
|
| Matrix Metalloproteinases | 1 | 2013 | 30 | 0.020 |
Why?
|
| Inflammation | 1 | 2019 | 1063 | 0.020 |
Why?
|
| Fibrinogen | 1 | 2013 | 52 | 0.020 |
Why?
|
| Apoptosis | 1 | 2019 | 1756 | 0.020 |
Why?
|
| Myosin Type II | 1 | 2013 | 50 | 0.020 |
Why?
|
| Blood Platelets | 1 | 2013 | 154 | 0.020 |
Why?
|
| Gene Rearrangement, B-Lymphocyte | 1 | 2012 | 37 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2013 | 396 | 0.020 |
Why?
|
| Aged | 2 | 2020 | 20927 | 0.020 |
Why?
|
| Lymphocytes | 1 | 2013 | 465 | 0.020 |
Why?
|
| Receptors, Notch | 1 | 2012 | 136 | 0.020 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2013 | 308 | 0.020 |
Why?
|
| Lymphoma, B-Cell | 1 | 2012 | 111 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2013 | 935 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2015 | 611 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2013 | 706 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2013 | 996 | 0.020 |
Why?
|
| Killer Cells, Natural | 1 | 2012 | 292 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2012 | 463 | 0.020 |
Why?
|
| Cell Line | 1 | 2012 | 2536 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2013 | 1275 | 0.020 |
Why?
|
| Prognosis | 1 | 2015 | 3993 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2013 | 2611 | 0.020 |
Why?
|
| Young Adult | 1 | 2019 | 7034 | 0.020 |
Why?
|
| Adolescent | 1 | 2019 | 9878 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2012 | 1309 | 0.010 |
Why?
|
| Adult | 1 | 2019 | 28636 | 0.010 |
Why?
|